FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
News|Articles|May 4, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of May 4, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 vaccinations, cases, and deaths in the US and on cases and deaths worldwide.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 44.5% of total US population has received at least 1 dose
• 32.0% of total US population is fully vaccinated
• 32.0% of total US population is fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Connecticut: 40.3%
2. Maine: 40.2%
3. Vermont: 39.3%
4. New Mexico: 39%
5. Massachusetts: 38.2%
2. Maine: 40.2%
3. Vermont: 39.3%
4. New Mexico: 39%
5. Massachusetts: 38.2%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 32 477 368 confirmed cases
• 577 671 deaths
• 577 671 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 747 337
2. Texas: 2 901 598
3. Florida: 2 245 853
4. New York: 2 057 276
5. Illinois: 1 341 671
2. Texas: 2 901 598
3. Florida: 2 245 853
4. New York: 2 057 276
5. Illinois: 1 341 671
Deaths: Deaths due to COVID-19 are highest in California with 61 967 reported fatalities, followed by New York with 52 423, and Texas with 50 331.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 153 676 825 confirmed cases, 3 216 016 deaths, and 90 377 597 recoveries.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Expands Baricitinib Approval to Adolescents With Severe Alopecia Areata
2
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
3
Stroke Incidence Nearly Doubled Among Adults Younger Than 55 Over 3 Decades
4
ACCORD Trials: Efficacy and Safety of Dextromethorphan-Bupropion in Agitation
5